The case for more intensive use of statins

Por Fulcher, Jordan, Keech, Anthony
Publicado em 2012

Recruitment to randomised studies

Por Hague, Wendy E, Gebski, Val J, Keech, Anthony C
Publicado no Med J Aust (2003)

An evaluation of the telehealth facilitation of diabetes and cardiovascular care in remote Australian Indigenous communities: - protocol for the telehealth eye and associated medic...

Por Brazionis, Laima, Jenkins, Alicia, Keech, Anthony, Ryan, Chris, Bursell, Sven-Erik
Publicado no BMC Health Serv Res (2017)

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

Por Bracken, Karen, Askie, Lisa, Keech, Anthony C, Hague, Wendy, Wittert, Gary
Publicado no BMJ Open (2019)

Shortening of telomere length by metabolic factors in diabetes: protective effects of fenofibrate

Por Sutanto, Surya Shin Ichi, McLennan, Susan Virginia, Keech, Anthony C., Twigg, Stephen Morris
Publicado no J Cell Commun Signal (2019)

An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes

Por Noonan, Jonathan E., Jenkins, Alicia J., Ma, Jian-Xing, Keech, Anthony C., Wang, Jie Jin, Lamoureux, Ecosse L.
Publicado em 2013

Biomarkers in Diabetic Retinopathy

Por Jenkins, Alicia J., Joglekar, Mugdha V., Hardikar, Anandwardhan A., Keech, Anthony C., O'Neal, David N., Januszewski, Andrzej S.
Publicado no Rev Diabet Stud (2015)

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models

Por Chen, Ying, Hu, Yang, Lin, Mingkai, Jenkins, Alicia J., Keech, Anthony C., Mott, Robert, Lyons, Timothy J., Ma, Jian-xing
Publicado em 2013

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

Por Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Publicado em 2009

Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials

Por Gencer, Baris, Marston, Nicholas A, Im, KyungAh, Cannon, Christopher P, Sever, Peter, Keech, Anthony, Braunwald, Eugene, Giugliano, Robert P, Sabatine, Marc S
Publicado no Lancet (2020)

FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease

Por Januszewski, Andrzej S., Watson, Chris J., O’Neill, Vikki, McDonald, Kenneth, Ledwidge, Mark, Robson, Tracy, Jenkins, Alicia J., Keech, Anthony C., McClements, Lana
Publicado no Sci Rep (2020)

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Por Rajamani, Kushwin, Colman, Peter G, Li, Li Ping, Best, James D, Voysey, Merryn, D'Emden, Michael C, Laakso, Markku, Baker, John R, Keech, Anthony C
Publicado em 2009

A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials

Por Simes, John, Voysey, Merryn, O'Connell, Rachel, Glasziou, Paul, Best, James D., Scott, Russell, Pardy, Christopher, Byth, Karen, Sullivan, David R., Ehnholm, Christian, Keech, Anthony
Publicado em 2010

Correction: A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials

Por Simes, John, Voysey, Merryn, O'Connell, Rachel, Glasziou, Paul, Best, James D., Scott, Russell, Pardy, Christopher, Byth, Karen, Sullivan, David R., Ehnholm, Christian, Keech, Anthony
Publicado em 2010

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

Por Best, James D., Drury, Paul L., Davis, Timothy M.E., Taskinen, Marja-Riitta, Kesäniemi, Y. Antero, Scott, Russell, Pardy, Christopher, Voysey, Merryn, Keech, Anthony C.
Publicado em 2012

The Relationship between Endothelial Progenitor Cell Populations and Epicardial and Microvascular Coronary Disease—A Cellular, Angiographic and Physiologic Study

Por Chan, Kim H., Simpson, Philippa J. L., Yong, Andy S., Dunn, Louise L., Chawantanpipat, Chirapan, Hsu, Chijen, Yu, Young, Keech, Anthony C., Celermajer, David S., Ng, Martin K. C.
Publicado em 2014

Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina

Por Ding, Lexi, Cheng, Rui, Hu, Yang, Takahashi, Yusuke, Jenkins, Alicia J., Keech, Anthony C., Humphries, Kenneth M., Gu, Xiaowu, Elliott, Michael H., Xia, Xiaobo, Ma, Jian-xing
Publicado em 2014

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Por Fonarow, Gregg C., Keech, Anthony C., Pedersen, Terje R., Giugliano, Robert P., Sever, Peter S., Lindgren, Peter, van Hout, Ben, Villa, Guillermo, Qian, Yi, Somaratne, Ransi, Sabatine, Marc S.
Publicado no JAMA Cardiol (2017)

Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data

Por Qamar, Arman, Giugliano, Robert P., Keech, Anthony C., Kuder, Julia F., Murphy, Sabina A., Kurtz, Christopher E., Wasserman, Scott M., Sever, Peter S., Pedersen, Terje R., Sabatine, Marc S.
Publicado no JAMA Cardiol (2018)

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

Por Scott, Russell, Donoghoe, Mark, Watts, Gerald F, O'Brien, Richard, Pardy, Christopher, Taskinen, Marja-Riitta, Davis, Timothy ME, Colman, Peter G, Manning, Patrick, Fulcher, Gregory, Keech, Anthony C
Publicado em 2011